Clinical Trial Update: Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating neurokinin-1 receptor antagonism to treat pruritus in patients with Sézary syndrome; the study was terminated and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sézary Syndrome

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Sezary Syndrome, Pruritus | Phase 4 | Status: TERMINATED | Results posted: 2017-05-10